Pharma channel feed – Endpoints News

Pharma channel feed

Pharmas spend millions on diabetes advertising, but few patients can recall brand names — survey

3 years ago

Faced with thousands of opioid lawsuits, Endo says it will likely file for bankruptcy 'imminently'

3 years ago

Bristol Myers flashes a thumbs-up on pivotal push to expand Abecma's BCMA CAR-T market

3 years ago

Feud between two biotechs left nearly 12M doses of monkeypox antiviral on the table

3 years ago

Updated: Amid massive restructuring, Biogen looks to reduce physical presence in Boston

3 years ago

Civica, Mayo Clinic and others sound off on FDA draft guidance to mitigate drug shortages

3 years ago

US weighs new route of administration for monkeypox vaccine as cases climb — report

3 years ago

Workers at Pfizer Australian manufacturing site the latest to walk out in labor dispute protests

3 years ago

'Messy at best': Is the US repeating the same Covid missteps with monkeypox messaging?

3 years ago

MarketingRx roundup: AbbVie refreshes Skyrizi and Rinvoq campaigns; Abbott inks WeightWatchers deal

3 years ago

US to stop supplying Lilly's mAb for Covid-19 this month as commercial market awaits

3 years ago

Novavax shares shredded as Covid vaccine sales fall more than 90% in Q2

3 years ago

In $1.36B biobuck deal with GSK, Mersana touts 'biggest preclinical ADC deal ever'

3 years ago

Despite falling Covid-19 sales, BioNTech maintains '22 sales guidance

3 years ago

GSK and IQVIA launch platform of US vaccination data, showing drop in adult rates

3 years ago

AbbVie surveys emotional impact of chronic leukemia condition, finds 'roller coaster' of emotions

3 years ago

AstraZeneca and Daiichi Sankyo sprint to market after FDA clears Enhertu in just two weeks

3 years ago

FDA's vaccine adcomm to review first fecal transplant to treat C. difficile infections

3 years ago

Pfizer and Myovant’s endometriosis pain drug Myfembree gets another FDA nod

3 years ago

Reata continues to hit FDA roadblocks with its Friedreich’s ataxia candidate, noting regulator 'concerns'

3 years ago

Eli Lilly eyes growth outside Indiana in wake of new abortion law — and New Jersey is ready

3 years ago

AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug

3 years ago

Senate Dems cling to a simple majority to pass some of the biggest drug pricing reforms ever

3 years ago

In a fresh disappointment, Amgen spotlights a major safety issue with KRAS combo

3 years ago

First page Previous page 181 182 183184185 186 187 Next page Last page